Aurelio A. Teleman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aurelio A. Teleman has a total of 463 co-authors. Here are the top co-authors by number of shared publications:
Katrin Strassburger
German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
11 shared publications- Constantinos Demetriades
Max Planck Institute for Biology of Ageing (MPI-AGE), Cologne, Germany
10 shared publications - Jonathan Bohlen
Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität, Munich, Germany, EU
10 shared publications Thomas Fleming
University of Heidelberg
9 shared publicationsSibylle Schleich
German Cancer Research Center (DKFZ) Heidelberg 1 , Division B140, 69120 Heidelberg
8 shared publicationsMarilena Lutz
Division of Signal Transduction in Cancer and Metabolism, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
7 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Springer Nature in Nature Cell Biology
- p. 1
Author Correction: Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor
- 22 October 2026
- Published by Springer Nature in Nature Cell Biology
- p. 1
Open AccessAuthor Correction: Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor
- Open Access
- 15 October 2026
- Published by Springer Nature in Nature Cell Biology
- p. 1
Author Correction: Remote control of AMPK via extracellular adenosine controls tissue growth
- 15 October 2026
- Published by Springer Nature in Nature Cell Biology
- p. 1
Open AccessAuthor Correction: Remote control of AMPK via extracellular adenosine controls tissue growth
- Open Access
- 14 October 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10784
Regulation of PDH via cysteine oxidation on DLAT
Pyruvate dehydrogenase (PDH) complex is a key regulator of metabolism, controlling flux from glycolysis into the tricarboxylic acid (TCA) cycle. PDH is often dysregulated in metabolic diseases and cancer. We discover here that in addition to its well characterized regulation by phosphorylation, PDH activity is also regulated via inhibitory oxidation of three cysteines of the DLAT subunit - Cys488, Cys586 and Cys618. Oxidation of these cysteines increases under oxidative stress, and is highly prevalent in mouse and human tissues. This mechanism enables cells to efficiently fight oxidative stress. Under oxidative stress, cells execute a metabolic shift, blocking glycolytic flux into the TCA cycle to shunt glycolytic carbons toward the pentose phosphate pathway. This generates NADPH which cells use to detoxify H 2 O 2 and to reduce oxidized cysteines. We find that DLAT oxidation is required for cells to mount an effective antioxidant response. Mutations preventing DLAT oxidation render PDH resistant to oxidative inhibition, impair NADPH generation, reduce peroxide detoxification, and sensitize cells to oxidative damage and death. DLAT oxidation also drives a Warburg-like metabolic phenotype of increased glucose uptake, elevated lactate secretion, and reduced TCA cycle activity. Thus DLAT oxidation is a redox-sensing mechanism that regulates PDH activity and central carbon metabolism.
- 14 October 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10784
Open AccessRegulation of PDH via cysteine oxidation on DLAT
Pyruvate dehydrogenase (PDH) complex is a key regulator of metabolism, controlling flux from glycolysis into the tricarboxylic acid (TCA) cycle. PDH is often dysregulated in metabolic diseases and cancer. We discover here that in addition to its well characterized regulation by phosphorylation, PDH activity is also regulated via inhibitory oxidation of three cysteines of the DLAT subunit - Cys488, Cys586 and Cys618. Oxidation of these cysteines increases under oxidative stress, and is highly prevalent in mouse and human tissues. This mechanism enables cells to efficiently fight oxidative stress. Under oxidative stress, cells execute a metabolic shift, blocking glycolytic flux into the TCA cycle to shunt glycolytic carbons toward the pentose phosphate pathway. This generates NADPH which cells use to detoxify H 2 O 2 and to reduce oxidized cysteines. We find that DLAT oxidation is required for cells to mount an effective antioxidant response. Mutations preventing DLAT oxidation render PDH resistant to oxidative inhibition, impair NADPH generation, reduce peroxide detoxification, and sensitize cells to oxidative damage and death. DLAT oxidation also drives a Warburg-like metabolic phenotype of increased glucose uptake, elevated lactate secretion, and reduced TCA cycle activity. Thus DLAT oxidation is a redox-sensing mechanism that regulates PDH activity and central carbon metabolism.
- Open Access
Stress induces DCP2 translation via a stalling-dependent mechanism
The integrated stress response (ISR) globally suppresses protein synthesis while selectively permitting translation of a small subset of stress-responsive mRNAs, many of which contain upstream or overlapping open reading frames (uORFs/oORFs). Although translational induction of transcripts such as ATF4 has classically been attributed to delayed re-initiation caused by reduced ternary complex availability, the mechanisms by which uORFs and oORFs allow ISR-selective translation remain incompletely understood. Here, using ribosome profiling during early ISR activation combined with reporter assays, we identify DCP2, encoding a major mRNA decapping enzyme, as a previously unrecognized ISR-induced transcript. We show that translational induction of DCP2 depends on an overlapping ORF whose conserved 3′ region, corresponding to a ribosome pausing site, acts as a potent inhibitory element. Both the DCP2 oORF and main ORF increase in translation during stress, indicating that stress relieves repression by this inhibitory element. This reveals a mode of ISR-dependent gene regulation in which inhibition by a nascent peptide or stalling element embedded either in a uORF or an oORF is relieved upon stress to induce translation.
Open AccessStress induces DCP2 translation via a stalling-dependent mechanism
The integrated stress response (ISR) globally suppresses protein synthesis while selectively permitting translation of a small subset of stress-responsive mRNAs, many of which contain upstream or overlapping open reading frames (uORFs/oORFs). Although translational induction of transcripts such as ATF4 has classically been attributed to delayed re-initiation caused by reduced ternary complex availability, the mechanisms by which uORFs and oORFs allow ISR-selective translation remain incompletely understood. Here, using ribosome profiling during early ISR activation combined with reporter assays, we identify DCP2, encoding a major mRNA decapping enzyme, as a previously unrecognized ISR-induced transcript. We show that translational induction of DCP2 depends on an overlapping ORF whose conserved 3′ region, corresponding to a ribosome pausing site, acts as a potent inhibitory element. Both the DCP2 oORF and main ORF increase in translation during stress, indicating that stress relieves repression by this inhibitory element. This reveals a mode of ISR-dependent gene regulation in which inhibition by a nascent peptide or stalling element embedded either in a uORF or an oORF is relieved upon stress to induce translation.
- Open Access
- 15 August 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (16)
Stress- and mitosis-dependent phosphorylation of NIFK on Ser247
NIFK is a nucleolar protein involved in ribosome biogenesis that interacts with Ki-67 (also known as MKI67) and is recruited to the perichromosomal layer during mitosis. NIFK expression is elevated in multiple cancers, and its expression correlates with poor prognosis. Although NIFK is highly phosphorylated, the regulation and functional significance of NIFK phosphorylation is not fully understood. Here, we identify Ser247 as a stress- and mitosis-responsive phosphorylation site on NIFK. Stress induces Ser247 phosphorylation through p38 mitogen-activated protein kinases (p38 MAPKs) and MSK1 (also known as RPS6KA5). Independently of stress, Ser247 is phosphorylated during mitosis by Aurora B (AURKB). In vitro assays confirm that MSK1 and Aurora B directly phosphorylate Ser247. During mitosis, Ser247 phosphorylation acts as a priming event enabling extensive multisite phosphorylation of NIFK. Mutation of Ser247 (S247A) abolishes this phosphorylation cascade but does not impair recruitment of NIFK to mitotic chromosomes. Nonetheless, cells with a NIFK S247A mutation display a delay in mitotic entry. Whether S247A mutation affects the ribosome biogenesis function of NIFK is not clear. These findings reveal that Ser247 is a hub integrating stress and mitotic cues, and establish it as a priming site for mitotic hyperphosphorylation of NIFK.
- 15 August 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (16)
Open AccessStress- and mitosis-dependent phosphorylation of NIFK on Ser247
NIFK is a nucleolar protein involved in ribosome biogenesis that interacts with Ki-67 (also known as MKI67) and is recruited to the perichromosomal layer during mitosis. NIFK expression is elevated in multiple cancers, and its expression correlates with poor prognosis. Although NIFK is highly phosphorylated, the regulation and functional significance of NIFK phosphorylation is not fully understood. Here, we identify Ser247 as a stress- and mitosis-responsive phosphorylation site on NIFK. Stress induces Ser247 phosphorylation through p38 mitogen-activated protein kinases (p38 MAPKs) and MSK1 (also known as RPS6KA5). Independently of stress, Ser247 is phosphorylated during mitosis by Aurora B (AURKB). In vitro assays confirm that MSK1 and Aurora B directly phosphorylate Ser247. During mitosis, Ser247 phosphorylation acts as a priming event enabling extensive multisite phosphorylation of NIFK. Mutation of Ser247 (S247A) abolishes this phosphorylation cascade but does not impair recruitment of NIFK to mitotic chromosomes. Nonetheless, cells with a NIFK S247A mutation display a delay in mitotic entry. Whether S247A mutation affects the ribosome biogenesis function of NIFK is not clear. These findings reveal that Ser247 is a hub integrating stress and mitotic cues, and establish it as a priming site for mitotic hyperphosphorylation of NIFK.
- Open Access
ATM-dependent RHEB phosphorylation couples DNA damage to lysosomal mTORC1 signaling to orchestrate the cellular response to genotoxic stress
Summary: Cells dynamically adapt to environmental stressors by rewiring signaling networks that coordinate growth, metabolism and genome maintenance. The DNA damage response (DDR) and mTORC1 signaling pathways govern DNA repair and cell growth, respectively, but how these pathways intersect remains incompletely understood. Here, we identify RHEB, the most direct mTORC1 activator, as a substrate of the DDR kinase ATM. Strikingly, we find that, although genotoxic stress differentially regulates mTORC1 activity—reducing the phosphorylation of its lysosomal target TFEB, while enhancing phosphorylation of its cytoplasmic target S6K—the DDR-induced phosphorylation of RHEB specifically controls the lysosomal mTORC1 signaling branch. Preventing RHEB phosphorylation impairs TFEB nuclear translocation and lysosome biogenesis upon DNA damage. Functionally, the RHEB phosphorylation-dependent TFEB response is required for proliferative recovery following genotoxic stress. These findings uncover an ATM-RHEB-mTORC1-TFEB signaling axis that links DNA damage to selective mTORC1 outputs, revealing a mechanism which enables cells to adapt to genotoxic cues.
Open AccessATM-dependent RHEB phosphorylation couples DNA damage to lysosomal mTORC1 signaling to orchestrate the cellular response to genotoxic stress
Summary: Cells dynamically adapt to environmental stressors by rewiring signaling networks that coordinate growth, metabolism and genome maintenance. The DNA damage response (DDR) and mTORC1 signaling pathways govern DNA repair and cell growth, respectively, but how these pathways intersect remains incompletely understood. Here, we identify RHEB, the most direct mTORC1 activator, as a substrate of the DDR kinase ATM. Strikingly, we find that, although genotoxic stress differentially regulates mTORC1 activity—reducing the phosphorylation of its lysosomal target TFEB, while enhancing phosphorylation of its cytoplasmic target S6K—the DDR-induced phosphorylation of RHEB specifically controls the lysosomal mTORC1 signaling branch. Preventing RHEB phosphorylation impairs TFEB nuclear translocation and lysosome biogenesis upon DNA damage. Functionally, the RHEB phosphorylation-dependent TFEB response is required for proliferative recovery following genotoxic stress. These findings uncover an ATM-RHEB-mTORC1-TFEB signaling axis that links DNA damage to selective mTORC1 outputs, revealing a mechanism which enables cells to adapt to genotoxic cues.
- Open Access
- 26 September 2025
- Published by Springer Nature in Nature Cell Biology
- Vol. 27 (10) , 1-11
Remote control of AMPK via extracellular adenosine controls tissue growth
Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a regulator of cellular catabolism that is activated by AMP. As AMP accumulates in cells with low ATP, AMPK is considered a stress-activated kinase. While studying organ growth during Drosophila development, we find that AMPK can also be activated by a signalling metabolite not related to stress. Specifically, we find that two physiological inputs known to regulate organ growth rates (ecdysone (a steroid hormone) and dietary protein) modulate expression of adenosine deaminase in the intestine. This, in turn, alters circulating adenosine levels. Circulating adenosine acts as a signalling molecule by entering cells, becoming phosphorylated to AMP and activating AMPK to inhibit organ growth. Thus, AMPK activity is regulated developmentally, and AMPK activity in one tissue can be remote controlled by another tissue via circulating adenosine. Notably, this mechanism accounts for half the effect of dietary protein on tissue growth rates in Drosophila.
- 26 September 2025
- Published by Springer Nature in Nature Cell Biology
- Vol. 27 (10) , 1-11
Open AccessRemote control of AMPK via extracellular adenosine controls tissue growth
Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a regulator of cellular catabolism that is activated by AMP. As AMP accumulates in cells with low ATP, AMPK is considered a stress-activated kinase. While studying organ growth during Drosophila development, we find that AMPK can also be activated by a signalling metabolite not related to stress. Specifically, we find that two physiological inputs known to regulate organ growth rates (ecdysone (a steroid hormone) and dietary protein) modulate expression of adenosine deaminase in the intestine. This, in turn, alters circulating adenosine levels. Circulating adenosine acts as a signalling molecule by entering cells, becoming phosphorylated to AMP and activating AMPK to inhibit organ growth. Thus, AMPK activity is regulated developmentally, and AMPK activity in one tissue can be remote controlled by another tissue via circulating adenosine. Notably, this mechanism accounts for half the effect of dietary protein on tissue growth rates in Drosophila.
- Open Access
The tumor suppressor CYLD acts as a deubiquitinase for mTOR to constrain its activity
Proper control of mTOR (mechanistic/mammalian target of rapamycin) signaling is relevant for health, disease and ageing. Information from intra- and extra-cellular signaling cues is transmitted to mTOR through an intricate signaling network that impinges on the Rag and Rheb GTPases to regulate its localization and activity. Interestingly, although mTOR is a heavily ubiquitinated protein, the role of this post- translational modification (PTM) in regulating its activation status remains poorly understood. Here, through an unbiased RNAi screen, we identified the tumor suppressor CYLD deubiquitinase (DUB) as a direct negative regulator of both mTORC1 and mTORC2 activities. Mechanistically, CYLD interacts with mTOR and removes non-degradative, K63-linked ubiquitin (Ub) chains from multiple of its residues. Consequently, CYLD loss-of-function cells are characterized by mTORC1/2 hyperactivation, elevated rates of protein synthesis, increased cell size, and resistance to serum-starvation-induced activation of cell death pathways. Moreover, silencing of cyld-1 , the C. elegans CYLD ortholog, fully reverses the extended lifespan of low- TORC1-activity mutant worms. Finally, we find that inactivation of CYLD is associated with hyperactivation of mTORC1 also in skin biopsies from CYLD cutaneous syndrome (CCS) patients. In sum, our findings highlight CYLD as a sentinel of mTOR hyperactivation via direct control of its ubiquitination, and suggest that dysregulated mTOR activity may contribute to the development and progression of CCS tumors.
Open AccessThe tumor suppressor CYLD acts as a deubiquitinase for mTOR to constrain its activity
Proper control of mTOR (mechanistic/mammalian target of rapamycin) signaling is relevant for health, disease and ageing. Information from intra- and extra-cellular signaling cues is transmitted to mTOR through an intricate signaling network that impinges on the Rag and Rheb GTPases to regulate its localization and activity. Interestingly, although mTOR is a heavily ubiquitinated protein, the role of this post- translational modification (PTM) in regulating its activation status remains poorly understood. Here, through an unbiased RNAi screen, we identified the tumor suppressor CYLD deubiquitinase (DUB) as a direct negative regulator of both mTORC1 and mTORC2 activities. Mechanistically, CYLD interacts with mTOR and removes non-degradative, K63-linked ubiquitin (Ub) chains from multiple of its residues. Consequently, CYLD loss-of-function cells are characterized by mTORC1/2 hyperactivation, elevated rates of protein synthesis, increased cell size, and resistance to serum-starvation-induced activation of cell death pathways. Moreover, silencing of cyld-1 , the C. elegans CYLD ortholog, fully reverses the extended lifespan of low- TORC1-activity mutant worms. Finally, we find that inactivation of CYLD is associated with hyperactivation of mTORC1 also in skin biopsies from CYLD cutaneous syndrome (CCS) patients. In sum, our findings highlight CYLD as a sentinel of mTOR hyperactivation via direct control of its ubiquitination, and suggest that dysregulated mTOR activity may contribute to the development and progression of CCS tumors.
- Open Access
- 21 July 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (17) , 4825-4866
mTORC1 senses glutamine and other amino acids through GCN2
MTORC1 promotes cell growth when nutrients such as amino acids are available. While dedicated sensors relaying availability of leucine, arginine and methionine to mTORC1 have been identified, it is still unclear how mTORC1 senses glutamine, one of its most potent inducers. Here, we find that glutamine is entirely sensed through the protein kinase GCN2, whose initial activation is not triggered by depletion of glutamine itself, but by the concomitant depletion of asparagine. In turn, GCN2 leads to a succession of events that additively inhibit mTORC1: within 1 h, GCN2 inhibits mTORC1 through the Rag GTPases, independently of its function as an eIF2α kinase. Later, GCN2-mediated induction of ATF4 upregulates Ddit4 followed by Sestrin2, which together cause additional mTORC1 inhibition. Additionally, we find that depletion of virtually any other amino acid also inhibits mTORC1 through GCN2. GCN2 and the dedicated amino acid sensors thus represent two independent systems that enable mTORC1 to perceive a wide spectrum of amino acids.
- 21 July 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (17) , 4825-4866
Open AccessmTORC1 senses glutamine and other amino acids through GCN2
MTORC1 promotes cell growth when nutrients such as amino acids are available. While dedicated sensors relaying availability of leucine, arginine and methionine to mTORC1 have been identified, it is still unclear how mTORC1 senses glutamine, one of its most potent inducers. Here, we find that glutamine is entirely sensed through the protein kinase GCN2, whose initial activation is not triggered by depletion of glutamine itself, but by the concomitant depletion of asparagine. In turn, GCN2 leads to a succession of events that additively inhibit mTORC1: within 1 h, GCN2 inhibits mTORC1 through the Rag GTPases, independently of its function as an eIF2α kinase. Later, GCN2-mediated induction of ATF4 upregulates Ddit4 followed by Sestrin2, which together cause additional mTORC1 inhibition. Additionally, we find that depletion of virtually any other amino acid also inhibits mTORC1 through GCN2. GCN2 and the dedicated amino acid sensors thus represent two independent systems that enable mTORC1 to perceive a wide spectrum of amino acids.
- Open Access
- 2 July 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Human eIF2A has a minimal role in translation initiation and in uORF-mediated translational control in HeLa cells
Translation initiation in eukaryotes requires a 40 S ribosome loaded with initiator tRNA which scans for an initiation codon. The initiator tRNA is usually recruited to the ribosome as part of a ternary complex composed of initiator tRNA, eIF2, and GTP. Although initiator tRNA recruitment was originally ascribed to another factor, eIF2A, it was later disproven and shown to occur via eIF2. Nonetheless, eIF2A is still considered a translation initiation factor because it binds the ribosome and shows genetic interactions with other initiation factors such as eIF4E. The exact function of eIF2A during translation initiation, however, remains unclear. Here, we use ribosome profiling and luciferase reporter assays to systematically test in HeLa cells the role of eIF2A in translation initiation, including translation of upstream ORFs. Since eIF2A is thought to take over the function of eIF2 when eIF2 is inhibited, we also test conditions where the integrated stress response is activated. In none of our assays, however, could we detect a role of eIF2A in translation initiation. It is possible that eIF2A plays a role in translation regulation in specific conditions that we have not tested here, or that it plays a role in a different aspect of RNA biology.
- 2 July 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessHuman eIF2A has a minimal role in translation initiation and in uORF-mediated translational control in HeLa cells
Translation initiation in eukaryotes requires a 40 S ribosome loaded with initiator tRNA which scans for an initiation codon. The initiator tRNA is usually recruited to the ribosome as part of a ternary complex composed of initiator tRNA, eIF2, and GTP. Although initiator tRNA recruitment was originally ascribed to another factor, eIF2A, it was later disproven and shown to occur via eIF2. Nonetheless, eIF2A is still considered a translation initiation factor because it binds the ribosome and shows genetic interactions with other initiation factors such as eIF4E. The exact function of eIF2A during translation initiation, however, remains unclear. Here, we use ribosome profiling and luciferase reporter assays to systematically test in HeLa cells the role of eIF2A in translation initiation, including translation of upstream ORFs. Since eIF2A is thought to take over the function of eIF2 when eIF2 is inhibited, we also test conditions where the integrated stress response is activated. In none of our assays, however, could we detect a role of eIF2A in translation initiation. It is possible that eIF2A plays a role in translation regulation in specific conditions that we have not tested here, or that it plays a role in a different aspect of RNA biology.